Showing results (281-290 of 632) with videos related to
Sort By:
Pageof 64
Biochemical Pharmacology|August 4, 1992
Inhibitory potency of some isatin analogues on human monoamine oxidase A and BA E Medvedev, B Goodwin, A Clow, et al.Cancer|January 1, 1983
Anaplastic myeloma with massive extramedullary involvement. Report of two casesK Foucar, M Raber, E Foucar, et al.Biochemical Pharmacology|May 1, 1984
Excretion of catecholamines and their metabolites in transplantable rat phaeochromocytomaG Rein, C R Ruthven, B L Goodwin, et al.The Journal of Urology|September 6, 2006
E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomesMichael E Ray, Rohit Mehra, Howard M Sandler, et al.Clinical Nuclear Medicine|February 1, 1984
Variation of the spleen-liver activity ratio due to a change in positionP T Makler, H A Goldstein, M G Velchik, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1984
Low platelet monoamine oxidase activity in headache: no correlation with phenolsulphotransferase, succinate dehydrogenase, platelet preparation method or smokingJ Littlewood, V Glover, M Sandler, et al.Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1989
Endogenous urinary monoamine oxidase inhibitor excretion in Parkinson's disease and other neurological disordersA Ueki, J Willoughby, V Glover, et al.International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Dose escalation for localized prostate cancer: substantial benefit observed with 3D conformal therapyZvi Symon, Kent A Griffith, P William McLaughlin, et al.Neuroscience Letters|October 28, 1991
Effect of aromatic amino acids, pentylenetetrazole and yohimbine on isatin and tribulin activity in rat brainS K Bhattacharya, A Clow, A Przyborowska, et al.Psychopharmacology|June 28, 1979
Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illnessA Coppen, V A Rama Rao, C R Ruthven, et al.Pageof 64